P0917n-acetyl cysteine fails to impact on plasma antioxidant capacity in both a placebo controlled crossover study and a parallel group trial of patients with ckd stage iii: implications for its use as a prophylactic for contrast induced nephropathy

Khuram Raja, Kirsty Hickson, Andrew Treweeke, Gordon Rushworth, Emma Morrison, Euan Sandilands, James Cobley, David McEneaney, Michael Eddleston, Ian Megson

Research output: Contribution to conferenceAbstract

Fingerprint

Dive into the research topics of 'P0917n-acetyl cysteine fails to impact on plasma antioxidant capacity in both a placebo controlled crossover study and a parallel group trial of patients with ckd stage iii: implications for its use as a prophylactic for contrast induced nephropathy'. Together they form a unique fingerprint.

Medicine and Dentistry